EX-10.1
from 8-K
9 pages
This Letter (This “Letter Agreement”) Is Being Delivered to You in Accordance With the Underwriting Agreement (The “Underwriting Agreement”) Entered Into by and Between PepperLime Health Acquisition Corporation, a Cayman Islands Exempted Company (The “Company”), and Oppenheimer & Co. Inc. (The “Underwriter”) on the Date Hereof, Relating to an Underwritten Initial Public Offering (The “Public Offering”), of Up to 17,250,000 of the Company’s Units (Including Up to 2,250,000 Units That May Be Purchased to Cover Over-Allotments, if Any) (The “Units”), Each Comprised of One Class a Ordinary Share of the Company, Par Value $0.0001 Per Share (Each an “Ordinary Share”), and One-Half (1/2) of One Redeemable Warrant (Each Whole Warrant, a “Warrant”). Each Whole Warrant Entitles the Holder Thereof to Purchase One Ordinary Share at a Price of $11.50 Per Share, Subject to Adjustment, as Described in the Prospectus (As Defined Below). the Units Will Be Sold in the Public Offering Pursuant to a Registration Statement on Form S-1 and Prospectus (The “Prospectus”) Filed by the Company With the U.S. Securities and Exchange Commission (The “Commission”) and the Company Has Applied to Have the Units Listed on the NASDAQ Global Market. Certain Capitalized Terms Used Herein Are Defined in Paragraph 10 Hereof
12/34/56